“We are proud to host experts from all over the world in Turin for a discussion on the latest frontiers of research that see EMN at the forefront”, comments Professor Mario Boccadoro, hematologist, president of EMN Trial Office and vice president of EMN. “For our academic studies and research, large numbers are essential, such as for vaccines, and very specialized professional figures such as data managers, capable of managing the large amount of data necessary in our field”.
New this year will be a session dedicated to ongoing clinical trials that have the potential to change clinical practice in myelomascheduled for Friday 19 April from 12.15pm to 1.15pm, with debates and discussions between haematological experts and selected commentators.
Another session of particular relevance and relevance, as well as great interaction, will be that of Saturday 20 April from 9.30 to 10.30, dedicated to innovations, artificial intelligence, CAR-T models and access to immunotherapy in real life.
In line with the two previous sessions, again on Saturday 19 April, from 12.40 to 13.20, a team of experts will discuss with the audience the future perspectives and what studies are actually necessary to change and improve the treatment of myeloma.
The meetingnow in its fifth edition, is organized by the EMN network with the support of EMN Trial Office, the Italian operational arm based in Turin within the Interdepartmental Center for Molecular Biotechnology – MBC, and in collaboration with ER Congressi. A unique opportunity for all those who work in the field of fighting blood cancers and a highly educational and educational event, in particular for young researchers, but also for nurses, data managers and study and research teams. Among the most anticipated focuses the application of artificial intelligence in the field of medical-scientific research.
Coordinators of the scientific program are the Professor Pieter Sonneveldthe Professor Sonja Zweegman and the Professor Niels van de Donk, representing the Dutch group; while the Italian part, which also deals with the organization of the Turin congress, will be composed of Professor Mario Boccadorofrom the Professor Francesca Gay and from Doctor Roberto Mina.
There are twelve European countries included in the EMN board: Austria with Prof. Heinz Ludwig, Francewith Prof. Philippe Moreau, Germany with Prof. Hermann Einsele, Greece with Prof. Meletios Athanasios Dimopoulos, Italy with the EMN Vice President Prof. Mario Boccadoro, Norway with Prof. Fredrik Schjesvold, Hollandwith the EMN President Prof. Pieter Sonneveld, Czech Republic with Prof. Roman Hajek, Spain with Prof. Jesus Fernando San-Miguele, Swisswith Prof. Christoph Driessen, Türkiyewith Prof. Meral Beksac e UK with Prof. Gordon Cook. Even more numerous (from all over Europe, the United States, Canada and Australia) are the countries of origin of the various speakers and moderators.
All information on the fifth Congress of the European Myeloma Network is available on official website emn2024.com.
